GEODE CAPITAL MANAGEMENT, LLC
Position in LKFT — Lakefront Biotherapeutics NV
CIK 1214717
BOSTON, MA
Position in LKFT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$304,297
-$203 QoQ
Shares Held
10,150
0.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 78 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LKFT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,870,628,057 across 520 Biotechnology names. LKFT ranks #383 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in LKFT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $304,297 | 10,150 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $304,500 | 10,150 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $256,727 | 7,851 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $271,958 | 7,851 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $219,749 | 7,851 | Shares | Defined | 2025-08-08 | |
| 2024-12-31 | $215,022 | 7,819 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $225,109 | 7,819 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $299,590 | 12,090 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $389,298 | 12,090 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $446,946 | 10,995 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $348,782 | 10,095 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $410,462 | 10,095 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $390,070 | 10,095 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $448,016 | 10,095 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $430,450 | 10,095 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $563,301 | 10,095 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $378,756 | 6,107 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $336,954 | 6,112 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $211,860 | 4,027 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $268,326 | 3,895 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $371,573 | 4,820 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $455,110 | 4,598 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $975,063 | 6,871 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,282,976 | 6,503 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,369,676 | 6,991 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||